T-lymphokine-activated killer-cell-originated protein kinase (TOPK), also known as PDZ-binding kinase (PBK), is a novel mitotic serine/threonine protein kinase, which was confirmed to be associated with the development, progression, and metastasis of malignancies and to be a potential therapeutic target in cancer therapy [30]. This evidence concerns the gene PBK and cancer.